Showing 461 - 480 results of 497 for search '"Фармакоэкономика"', query time: 0.05s Refine Results
  1. 461
    Pharmacoeconomic efficacy of atesolizumab compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy

    Pharmacoeconomic efficacy of atesolizumab compared with other PD-1 inhibitors in patients with advanced non-small cell lung cancer after chemotherapy by S. K. Zyryanov, I. N. Diyakov

    Published 2020-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 462
    PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA

    PHARMACOECONOMIC ANALYSIS OF VESOMNI (SOLIFENACIN AND CONTROLLED RELEASE TAMSULOSIN) TREATMENT OF STORAGE SYMPTOMS ASSOCIATED WITH BENIGN PROSTATIC HYPERPLASIA by N. A. Avxentyev, M. Yu. Frolov

    Published 2016-09-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 463
    EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS

    EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS by M. Yu. Frolov, V. A. Rogov

    Published 2017-05-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 464
    PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE by A. U. Kulikov, I. A. Komarov

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 465
    Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients

    Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients by N. K. Mazina, P. V. Mazin

    Published 2017-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 466
    MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016

    MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 by A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum

    Published 2016-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 467
    Efficiency of Levilimab in patients with moderate and severe COVID-19

    Efficiency of Levilimab in patients with moderate and severe COVID-19 by Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A.  S. Kolbin, M. V. Livshits, T.  A. Usmanova, A. M. Fakhrutdinova, Yu. S.  Konstantinova, A. P. Gubanov

    Published 2023-04-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 468
    An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis

    An open-label, controlled trial of the clinical effects of Laennec® in patients with nonalcoholic steatohepatitis or cirrhosis by M. Imawari, M. Nagase, I. Yu. Torshin, O. A. Gromova

    Published 2023-11-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 469
    Antibiotic resistance of uropathogens in patients with nephrolithiasis and concomitant coronary heart disease

    Antibiotic resistance of uropathogens in patients with nephrolithiasis and concomitant coronary heart disease by R. V. Royuk, S. K. Yarovoy, I. B. Shikina

    Published 2023-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 470
    RESEARCH EXCELLENCE INDEX AS INSTRUMENT OF PERFORMANCE-ORIENTED BUDGETING

    RESEARCH EXCELLENCE INDEX AS INSTRUMENT OF PERFORMANCE-ORIENTED BUDGETING by O. V. Bogacheva, V. E. Grigorov

    Published 2015-12-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 471
    PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS

    PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS by Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova

    Published 2015-09-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 472
    PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION

    PHARMACOECONOMIC JUSTIFICATION OF A WIDER USE OF PREVENTIVE HEMOPHILIA THERAPY IN THE RUSSIAN FEDERATION by M. Yu. Frolov, V. A. Rogov

    Published 2018-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 473
    PROPOSALS AND RECOMMENDATIONS FOR OPTIMIZATION OF THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS

    PROPOSALS AND RECOMMENDATIONS FOR OPTIMIZATION OF THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS by D. V. Fedyaev, D. V. Lukyantseva, V. I. Ignatyeva

    Published 2017-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 474
    Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia

    Pharmacoeconomic analysis of treatment with nilotinib as the second line therapy in patients with chronic myeloid leukemia by N. A. Avxentyev, M. Yu. Frolov, A. S. Makarov

    Published 2018-08-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 475
    Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis

    Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis by I. A. Narkevich, O. D. Nemyatyh, D. D. Siukaeva, I. V. Pavlushkov, D. O. Ivanov, Ya. V. Panyutina

    Published 2019-01-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 476
    ABC-, VEN- AND FREQUENCY ANALYSIS OF TREATMENT OF ATRIAL FIBRILLATION IN OUTCOME PATIENTS

    ABC-, VEN- AND FREQUENCY ANALYSIS OF TREATMENT OF ATRIAL FIBRILLATION IN OUTCOME PATIENTS by A. N. Korobeynikova, S. V. Malchikova

    Published 2016-02-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 477
    Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union

    Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union by A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich

    Published 2020-08-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 478
    Comparative effectiveness of simultaneous and staged operations in patients with atherosclerotic lesions of carotid and coronary arteries

    Comparative effectiveness of simultaneous and staged operations in patients with atherosclerotic lesions of carotid and coronary arteries by A. B. Ismoilova, N. M.U. Sultanbaeva, A. A. Abdurakhmanov, Sh. Z. Umarova, D. Kh. Dzhalalova, S. Ch. Dzhalalov

    Published 2021-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 479
    VII CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION»

    VII CONGRESS WITH INTERNATIONAL PARTICIPATION «DEVELOPMENT OF PHARMACOECONOMICS AND PHARMACOEPIDEMIOLOGY IN RUSSIAN FEDERATION»

    Published 2015-03-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 480
    Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis

    Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis by A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova

    Published 2021-07-01
    “…Фармакоэкономика…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: